Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Danaos Corporation (DAC) vs UnitedHealth Group Inc (UNH) Price & Performance

Danaos CorporationTrade
UnitedHealth Group IncTrade

Price performance (Past 24H)

Key statistics

Danaos Corporation vs UnitedHealth Group Inc — how do they compare? Danaos Corporation trades at $169.09 (market cap $3.10B), while UnitedHealth Group Inc trades at $379.3 (market cap $332.96B). The key difference: UnitedHealth Group Inc is far larger — about 107.4× Danaos Corporation's market cap, and UnitedHealth Group Inc pays the higher dividend (2.5%). Which is the better fit depends on your goals — on Pluang, investors hold Danaos Corporation for 25 Days and UnitedHealth Group Inc for 97 Days on average.

DACUNH
Market Cap
$3.10B$332.96B
Volume
286,0087,273,749
Sector
IndustrialsHealth
52-Week High
$170.22$436.35
52-Week Low
$84.05$259.02
Typical Hold Time
25 Days97 Days
Enterprise Value
$3.08B$374.82B
Dividend Yield
2.35%2.5%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Danaos Corporation

DAC trades at $169.09, up 2.8% today, with a bullish technical signal and strong fundamental metrics. The company reported robust earnings beats in recent quarters, with Q2 2026 EPS of $7.29 exceeding the $6.80 estimate. Valuation ratios are attractive, including a P/E of 5.76 and P/B of 0.76, while profitability remains high with a net income margin of 51.26%. Recent news highlights dividend declarations and institutional investment interest.

The outlook is positive given earnings momentum and shareholder returns via dividends, but risks include shipping market volatility and reliance on global trade flows. Analyst consensus is evenly split between Buy and Hold ratings, suggesting cautious optimism amid strong operational performance.

UnitedHealth Group Inc

UnitedHealth Group (UNH) trades at $370.95, down 1.34% on the day, amid a bearish technical signal from moving averages. The company reported strong Q2 2026 earnings, beating estimates with EPS of $6.38 versus $4.91 expected, and raised full-year guidance. Revenue for 2025 reached $447.57 billion, though net income margin declined to 2.69%. Analyst consensus remains strongly bullish with an 82.69% buy rating and a $470.11 price target, suggesting significant upside from current levels.

UNH presents a compelling investment case driven by earnings beats, raised 2026 outlook, and strategic initiatives like AI investment in Optum. Key risks include regulatory pressures in healthcare, volatility from Medicare Advantage plan changes, and margin compression. The stock's valuation at a P/E of 23.84 appears reasonable given growth prospects, but investors should weigh execution risks against the positive analyst sentiment and institutional backing.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

DAC
100% Buy0% Sell
Avg holding period · 25 Days
UNH
71% Buy29% Sell
Avg holding period · 97 Days

Top news

Latest headlines on both assets

About Danaos Corporation

Danaos is a leading international owner of containerships, providing seaborne transportation services globally. It charters its fleet of vessels to major shipping lines across Asia, Europe, and the Americas.

Read more on DAC →

About UnitedHealth Group Inc

UnitedHealth Group is one of the largest private health insurers, providing medical benefits to 50 million members globally, including 5 million outside the U.S. at the end of 2021. As a leader in employer-sponsored, self-directed, and government-backed insurance plans, UnitedHealth has obtained massive scale in managed care. Along with its insurance assets, UnitedHealth's continued investments in its Optum franchises have created a healthcare services colossus that spans everything from medical and pharmaceutical benefits to providing outpatient care and analytics to both affiliated and third-party customers.

Read more on UNH →